LAFCX
Price
$19.33
Change
-$0.20 (-1.02%)
Updated
Jun 13 closing price
Net Assets
6.01B
VVIAX
Price
$67.63
Change
-$0.55 (-0.81%)
Updated
Jun 13 closing price
Net Assets
188.77B
Interact to see
Advertisement

LAFCX vs VVIAX

Header iconLAFCX vs VVIAX Comparison
Open Charts LAFCX vs VVIAXBanner chart's image
Lord Abbett Affiliated C
Price$19.33
Change-$0.20 (-1.02%)
VolumeN/A
Net Assets6.01B
Vanguard Value Index Adm
Price$67.63
Change-$0.55 (-0.81%)
VolumeN/A
Net Assets188.77B
LAFCX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAFCX vs. VVIAX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAFCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. LAFCX (6.01B). VVIAX pays higher dividends than LAFCX: VVIAX (2.28) vs LAFCX (0.83). LAFCX was incepted earlier than VVIAX: LAFCX (29 years) vs VVIAX (25 years). LAFCX (1.44) is less costly to investors than VVIAX (0.05). LAFCX is a more actively managed with annual turnover of: 44.00 vs. VVIAX (9.00). LAFCX has a lower initial minimum investment than VVIAX: LAFCX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 8.01 vs. LAFCX (6.56). VVIAX return over 5 years is better than : 72.56 vs. LAFCX (52.41).
LAFCXVVIAXLAFCX / VVIAX
Total Expense Ratio1.440.052,880%
Annual Report Gross Expense Ratio1.440.052,880%
Fund Existence29 years25 years-
Gain YTD3.1552.436129%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets6.01B189B3%
Annual Yield % from dividends0.832.2836%
Returns for 1 year6.568.0182%
Returns for 3 years27.9332.1987%
Returns for 5 years52.4172.5672%
Returns for 10 years27.29103.5426%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XYLO4.96-0.03
-0.60%
Xylo Technologies Ltd
ECX1.58-0.01
-0.63%
ECARX Holdings
MTZ162.10-1.20
-0.73%
MasTec
IBRX3.07-0.12
-3.76%
ImmunityBio
RAPT1.04-0.05
-4.59%
RAPT Therapeutics